The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).

  • Authors:
    • C T To
    • M S Tsao
  • View Affiliations

  • Published online on: September 1, 1998     https://doi.org/10.3892/or.5.5.1013
  • Pages: 1013-1037
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The protein product of c-met proto-oncogene, Met, is a tyrosine kinase receptor for the hepatocyte growth factor (HGF), also known as the scatter factor (SF). HGF/SF-Met signaling has multifunctional effects on mammalian cells. These include stimulation or inhibition of cellular proliferation, promotion of cell movement, invasion into extracellular matrix, and induction of glandular/tubular morphogenesis by epithelial cells. There is a substantial body of experimental evidence that supports the oncogenic role of HGF/SF-Met signaling pathways. This is putatively mediated by autocrine or paracrine mechanisms that promote tumor cell growth, invasion and angiogenesis. We review the evidence that HGF/SF and Met receptor play significant roles in the pathogenesis and biology of human cancers.

Related Articles

Journal Cover

Sep-Oct 1998
Volume 5 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
To C and To C: The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).. Oncol Rep 5: 1013-1037, 1998
APA
To, C., & To, C. (1998). The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).. Oncology Reports, 5, 1013-1037. https://doi.org/10.3892/or.5.5.1013
MLA
To, C., Tsao, M."The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).". Oncology Reports 5.5 (1998): 1013-1037.
Chicago
To, C., Tsao, M."The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).". Oncology Reports 5, no. 5 (1998): 1013-1037. https://doi.org/10.3892/or.5.5.1013